Finance

Lists
Why is EVGN down 4,09%?
Dive Deeper
EVGN:NASDAQ
Evogene Ltd
0,38 US$
-4,09%
(-0,016) 1D
9 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EVGN...
Open
0,39 US$
High
0,39 US$
Low
0,37 US$
Mkt. cap
6,90 მლნ.
Avg. vol.
2,57 მლნ.
Volume
106,04 ათ.
52-wk high
1,49 US$
52-wk low
0,35 US$
EPS
-0,90 US$
Beta
1,44
Shares outstanding
18,05 მლნ.
No. of employees
52
Open
0,39 US$
High
0,39 US$
Low
0,37 US$
Mkt. cap
6,90 მლნ.
Avg. vol.
2,57 მლნ.
Volume
106,04 ათ.
52-wk high
1,49 US$
52-wk low
0,35 US$
EPS
-0,90 US$
Beta
1,44
Shares outstanding
18,05 მლნ.
No. of employees
52
News stories
From web sources and news partners
Stock Traders Daily
Stock Traders Daily
·
4 საათის წინ
(CVCO) Risk Channels and Responsive Allocation
Yahoo Finance
Yahoo Finance
·
11 საათის წინ
A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
MyStateline
MyStateline
·
1 დღის წინ
Wall Street finishes its record-setting week with gains
Profile
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs. In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
About Evogene Ltd
CEOოფერ ჰავივ
Employees52
Founded1999
Headquarters-
Sector-
Analyst
Recommendation
Action
Price target
Projected
Date
Scott Henry
Alliance Global Partners
Buy
Maintained
2,15 US$
+462,5%
05/26/2026
Unknown Analyst
Alliance Global Partners
Buy
Maintained
1,75 US$
+357,9%
03/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
312,00 ათ.
314,00 ათ.
334,00 ათ.
347,00 ათ.
Cost of goods sold
157,00 ათ.
2,28 მლნ.
130,00 ათ.
206,00 ათ.
Cost of revenue
157,00 ათ.
2,28 მლნ.
130,00 ათ.
206,00 ათ.
Research and development expenses
1,38 მლნ.
1,83 მლნ.
1,84 მლნ.
1,10 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,50 მლნ.
1,20 მლნ.
1,54 მლნ.
1,15 მლნ.
Operating expense
2,88 მლნ.
3,00 მლნ.
3,38 მლნ.
2,25 მლნ.
Total operating expenses
3,04 მლნ.
5,28 მლნ.
3,51 მლნ.
2,45 მლნ.
Operating income
-2,72 მლნ.
-4,97 მლნ.
-3,18 მლნ.
-2,10 მლნ.
Other non operating income
-
668,00 ათ.
-
-1,70 მლნ.
EBT including unusual items
-2,73 მლნ.
-5,34 მლნ.
-5,91 მლნ.
-1,26 მლნ.
EBT excluding unusual items
-2,73 მლნ.
-5,09 მლნ.
-5,94 მლნ.
-1,13 მლნ.
Income tax expense
1,00 ათ.
-
4,00 ათ.
-4,00 ათ.
Effective tax rate
-0,04%
-
-0,07%
0,32%
Other operating expenses
9,00 ათ.
-27,00 ათ.
-
-
Net income
3,87 მლნ.
-5,31 მლნ.
-5,87 მლნ.
-1,77 მლნ.
Net profit margin
1 241,67%
-1 690,76%
-1 757,48%
-509,51%
Earnings per share
-0,46
-0,62
-0,61
-0,13
Interest and investment income
465,00 ათ.
1,38 მლნ.
1,17 მლნ.
3,65 მლნ.
Interest expense
-453,00 ათ.
-1,93 მლნ.
-3,88 მლნ.
-975,00 ათ.
Net interest expenses
12,00 ათ.
-545,00 ათ.
-2,71 მლნ.
2,68 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,44 მლნ.
-4,70 მლნ.
-2,98 მლნ.
-1,97 მლნ.
Gain or loss from assets sale
12,00 ათ.
-27,00 ათ.
-23,00 ათ.
9,00 ათ.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები